Sonoma Pharmaceuticals (SNOA) Q1 2026 Earnings

10FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.73
-0.53
-0.33
-0.13

Details

Expected EPS
-0.29
Actual EPS
-0.35157
Surprise EPS
-0.06
Surprise Percent
+21.23%

Description

Sonoma Pharmaceuticals (SNOA) has reported earnings of -0.35157 per share for Q1 2026.

0 Comments

Share your thoughts